TORONTO, June 11, 2020 /CNW/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid ...
Leading GPO Selects MolecuLight i:X Point-of-Care Device as a Key Tool for Informing its National Long-Term Care Membership on the Presence of Elevated Bacterial Burden in Patients' Wounds VALLEY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback